Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
biogen
3
×
boston blog main
boston top stories
3
×
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
3
×
clinical trials
deals
3
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
3
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aducanumab
aduro biotech
affordable care act
biotech
cancer
cancer immunotherapy
eli lilly
gilead sciences
glaxosmithkline
What
bio
roundup
biogen’s
drug
nash
news
aducanumab
alliance
alzheimer’s
amyloid
angst
approval
bagged
billions
biogen
biopharmaceutical
brammer
bristol
buy
calls
changing
color
companies
convo
crispr
days
earlier
effects
failure
failures
felt
growing
hours
kudos
leaves
littered
lost
myers’s
new
notifying
Language
unset
Current search:
biogen
×
" san francisco top stories "
×
" bristol-myers squibb "
×
" boston top stories "
×
deals
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More